日本語 >>
TOP page
Journal
Presentation
Belonging society
(Last updated : 2023-07-18 23:35:32)
Yuji Nojima
Department
Kawasaki Medical School Kawasaki Medical School, Department of General Thoracic Surgery,
Position
Assistant Professor
■
Journal
1.
2022/03/23
A case of pleuroperitoneal communication during long-term steroid therapy for dermatomyositis
2.
2021/11
Tumor PD-L1 and VEGF Expression, and CD8 T Cell Infiltration Predict Clinical Response to Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
3.
2021/08/06
The biological Characteristics of Solid Components are Different between Part-Solid-Type and Solid-Type in Lung Adenocarcinoma
4.
2021/01/24
Tofacitinib overcomes an IFNγ‐induced decrease in NK cell‐mediated cytotoxicity via the regulation of immune‐related molecules in LC‐2/ad
5.
2020/09/01
Perioperative Therapy for Non-Small Cell Lung Cancer - Current Status and Future Perspective -
6.
2019/11/26
Clinicopathological relevance of tumor expression of NK group 2 member D ligands in resected non-small cell lung cancer
7.
2019/08
Effect of platinum-based chemotherapy on the expression of natural killer group 2 member D ligands, programmed cell death-1 ligand 1 and HLA class I in non-small cell lung cancer
8.
2019/05
Comparative study of the PD-L1 expression and CD8+ tumor-infiltrating lymphocyte between surgically resected and matched re-biopsy specimens in recurrent non-small cell lung cancer
9.
2018/10
Deciduoid type malignant pleural mesothelioma: a case report
10.
2018/08
Impact of COX2 Inhibitor for Regulation of PD-L1 Expressioin in Non-small Cell Lung Cancer
11.
2017/10
Prognostic value of Cox-2 and PD-L1 expression and its relationship with tumor-infiltrating lymphocytes in resected lung adenocarcinoma.
12.
2017/08
Urinary levels of prostaglandin E2 are positively correlated with intratumoral infiltration of Foxp3+ regulatory T cells in non-small cell lung cancer.
13.
2017/07
PD-L1 overexpression is partially regulated by EGFR/HER2 signaling and associated with poor prognosis in patients with non-small-cell lung cancer.
14.
2016/12
Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings
15.
2016/03
MHC class I chain-related molecule A and B expression is upregulated by cisplatin and associated with good prognosis in patients with non-small-cell lung cancer
16.
2015/12
Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity via upregulation of HER2 in malignant mesothelioma cells.
17.
2015/09
Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer
18.
2015/09
Prognostic nutritional index before adjuvant chemotherapy predicts chemotherapy compliance and survival among patients with non-small cell lung cancer
19.
2015/08
Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer.
20.
2015/02
Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy.
21.
2014/11
Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma and squamous cell carcinoma.
22.
2014
Clinical significance of vascular endothelial growth factor and Delta-like ligand 4 in small pulmonary adenocarcinoma
23.
2013
CT, MRI, and 18F-FDG PET-CT findings of pulmonary benign metastasizing leiomyoma: A case report
Display 5 items
Display all(23)
■
Presentation
1.
2023/04/27
Informed Consent in Surgery for Primary Lung Cancer (Speech,Panelist at Symposium/Workshop (Applied))
2.
2016/12/07
Comparison of Clinicopathological and Immunohistochemical features in Lung Invasive Mucinous Adenocarcinomaaccording to Computed Tomography Findings. (Poster notice,General)
■
Belonging society
1.
2011~
Japan Surgical Society
2.
2013/12~
General Thoracic and Cardiovascular Surgery